“Let’s say it wears an Ebola Coat, but it’s not Ebola”: The Rhetoric and Politics of Reframing a Vaccine for a Transnational Clinical Trial

Oumy Thiongane; Issiaka Bamba; Hélène N Sawadogo; Pierre-Marie David; Benjamin Mathiot; Janice E Graham

doi:10.18357/anthropologica66120242643

Authors

Oumy Thiongane CIRAD, ASTRE (Animals Health Territories Risks and Ecosystems), Research associate Dalhousie University
Issiaka Bamba Centre Muraz, Bobo Dioulasso, Burkina Faso
Hélène N Sawadogo Department of Sociology, Joseph KI Zerbo University of Ouagadougou, Laboratoire Groupe de Recherche sur les Initiatives Locales (GRIL), Burkina Faso
Pierre-Marie David Faculté́ de Pharmacie, University of Montreal, C.P. 6128, Succursale Centre‐Ville, Montreal H3C 3J7, Canada. https://orcid.org/0000-0001-7441-0633
Benjamin Mathiot Department of anthropology, University of Montreal, Pavillon Lionel‐Groulx C. P. 6128, Succursale Centre‐Ville, Montreal, QC H3C 3J7, Canada https://orcid.org/0009-0008-9954-4150
Janice E Graham Technoscience Regulation and Research Unit, Dalhousie University, Halifax, Canada https://orcid.org/0000-0002-6326-8122

DOI:

https://doi.org/10.18357/anthropologica66120242643

Keywords:

manufacturing consent, community engagement, vaccine clinical trial, Ebola, HIV

Abstract

Focusing on how disease, health and vaccine research take on different forms, meanings and interpretations in diverse contexts, we examine the use of rhetoric to recruit people living with HIV in sub-Saharan Africa for an Ebola vaccine clinical trial. Conducted after the West African Ebola outbreak in a country that had not been affected by Ebola, the urgency, relevance and materiality of disease, health and biomedical research takes on different shapes, meanings and understandings. The limitations of multilateral initiatives to address inequalities in associated healthcare and access to essential medicines and vaccines highlight the tensions created when neither local researchers nor patient communities have been involved in the design or planning of the trial, and when the pathologies targeted by experimental technologies are either inappropriate for the people they are aimed at, or unfold without the knowledge of a social consensus.

By deciphering the metaphorical discourse on an Ebola vaccine candidate and the erasure of a viral ontology from the hybrid technology to which it gives rise, we understand that the discourse of clinic staff makes it possible to establish a scientific truth in the service of instrumental productivity: manufacturing consent and recruiting arms for vaccine shots.

In this article, we show that the closure of biomedicine to an esoteric discourse reflects the weakness of science in communicating what it actually does and the techniques it produces. It also addresses the failure of community engagement in the field of emerging infectious diseases.

Downloads

Download data is not yet available.

References

Abramowitz, Sharon Alane, Kristen E. McLean, Sarah Lindley McKune, Kevin Louis Bardosh, Monger Fallah Mosoka , Josephine Kodjo Tehoungue, Patricia A. Omidian. 2015. “Community-Centered Responses to Ebola in Urban Liberia: The View from Below.” PLOS Neglected Tropical Diseases 9 (4). https://doi.org/10.1371/journal.pntd.0003706. DOI: https://doi.org/10.1371/journal.pntd.0003706

Adams, Vincanne. 2013. “Evidence-Based Global Public Health: Subjects, Profits, Erasures.” In When People Come First: Critical Studies in Global Health, edited by Joao Biehl and Adriana Petryna, 54–90. Princeton: Princeton University Press. DOI: https://doi.org/10.1515/9781400846801-004

Alazard-Dany, Nathalie, Michèle Ottmann Terrangle, and Viktor Volchkov. 2006. “Ebola et Marburg : les hommes contre-attaquent.” Médecine/Sciences 22 (4): 405–410. https://doi.org/10.1051/medsci/2006224405. DOI: https://doi.org/10.1051/medsci/2006224405

Benton, Adia. 2018. “Why We Should Be Cautious about the ‘Game-Changer’ Ebola Vaccine.” Aljazeera, 30 May. https://www.aljazeera.com/opinions/2018/5/30/why-we-should-be-cautious-about-the-game-changer-ebola-vaccine (accessed 23 May 2023).

Benton, Adia. 2015b. HIV Exceptionalism: Development through disease in Sierra Leone. Minneapolis: University of Minnesota Press. DOI: https://doi.org/10.5749/minnesota/9780816692422.001.0001

Berthé, Abdramane, Nicolas Meda, Isidore T. Traoré, Jérôme Some, Souleymane Salouka, Lalla Sanou, Felicien Some, Jeremy Rouamba, Djenaba Ouedraogo, Gilles M’Boutiki, Philippe Mayaud, Nicolas Nagot, Philippe Van de Perre. 2009. “Preparation for HIV Vaccine Trials in Africa: Barriers and Facilitators for the Establishment of a Community Advisory Board in Burkina Faso.” Retrovirology 6 (3) (22 October): 226. https://doi.org/10.1186/1742-4690-6-S3-P226. DOI: https://doi.org/10.1186/1742-4690-6-S3-P226

Bosia, Micheal. 2011. “SIDA et politiques postcoloniales. Act-up face à la science et à l’idéologie universaliste en France.” In Les Suds face au SIDA: quand la société civile se mobilise, edited by Fred Eboko, Frédéric Bourdier and Christophe Broqua, 333–369. Marseille: IRD. DOI: https://doi.org/10.4000/books.irdeditions.3499

Boum II Yap. 2018. “Is Africa Part of the Partnership?” Medicine Anthropology Theory 5 (2). https://doi.org/10.17157/mat.5.2.527. DOI: https://doi.org/10.17157/mat.5.2.527

Colvin, Christopher J. 2011. “HIV/AIDS, Chronic Diseases and Globalization.” Globalization and Health. 7 (1): 31. https://doi.org/10.1186/1744-8603-7-31. DOI: https://doi.org/10.1186/1744-8603-7-31

Couderc, Mathilde and Caroline Desclaux Sall. 2012. Du patient au réseau : construction de la dynamique communautaire. Dakar. https://halshs.archives-ouvertes.fr/halshs-00712808/document.

David, Pierre-Marie, Benjamin Mathiot, Oumy Thiongane, Janice E. Graham. 2021. “Under Consent: Participation of People with HIV in an Ebola Vaccine Trial in Canada.” BMC Medical Ethics 22 (1): 42. https://doi.org/10.1186/s12910-021-00606-6. DOI: https://doi.org/10.1186/s12910-021-00606-6

Davtyan, Mariam, Brandon Brown, and Morenike Oluwatoyin Folayan. 2014. “Addressing Ebola-related Stigma: Lessons Learned from HIV/AIDS.” Global Health Action 7 (1): 26058. https://doi.org/10.3402/gha.v7.26058. DOI: https://doi.org/10.3402/gha.v7.26058

Eboko, Fred and P.Y. Mandjem. 2011. “ONG et associations de lutte contre le sida en Afrique : incitations transnationales et ruptures locales au Cameroun.” In Les Suds face au sida : quand la société civile se mobilise, edited by Fred Eboko, Frédéric Bourdier, and C. Broqua, 205–230. Marseille: IRD. http://www.documentation.ird.fr/hor/fdi:010051858. DOI: https://doi.org/10.4000/books.irdeditions.3493

Faye, Sylvain, Birane Landry, Waly Diouf, Papa Ndiaga Cisse, Alexandre Quach, Malick Minkael Sylla, Moussa Makalo Koita, Simon Gbanamou, Billy Sivahera Muyisa, Éric D’Ortenzio, Abdoul Habib Beavogui. 2018. “Engager (avec) les communautés dans un essai vaccinal en contexte post-Ebola (Guinée Conakry) : un modèle basé sur les ‘champions’.” Sciences et Actions Sociales 10 (2): 112–141. https://doi.org/10.3917/sas.010.0112. DOI: https://doi.org/10.3917/sas.010.0112

Gausset, Quentin, Hanne Overgaard Mogensen, Maurice Evariste Yameogo Wambi, Berthé Abdramane, and Konaté Blahima. 2012. “The Ambivalence of Stigma and the Double-Edged Sword of HIV/AIDS Intervention in Burkina Faso.” Social Science and Medicine 74 (7): 1037–1044. https://doi.org/10.1016/j.socscimed.2011.11.044. DOI: https://doi.org/10.1016/j.socscimed.2011.11.044

Gomez-Temesio, Veronica and Frédéric Le Marcis. 2017. La mise en camp de la Guinée : Ebola et l’expérience postcoloniale. Homme 222: 57–90. https://shs.cairn.info/revue-l-homme-2017-2-page-57?lang=fr DOI: https://doi.org/10.4000/lhomme.30147

Government of Canada. 2020. National Advisory Committee on Immunization Interim Statement on the Use of the rVSVΔG-ZEBOV-GP Vaccine for the Prevention of Ebola Virus Disease. Government of Canada. https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/interim-statement-vaccine-prevention-ebola-virus-disease.html.

Graham, Janice E. 2019. “Ebola Vaccine Innovation: A Case Study of Pseudoscapes in Global Health.” Critical Public Health 29 (4): 401–412. https://doi.org/10.1080/09581596.2019.1597966. DOI: https://doi.org/10.1080/09581596.2019.1597966

Henao-Restrepo, Ana Maria, Marie-Pierre Preziosi, David Wood, Vasee Moorthy, and Marie Paule Kieny. 2016. “On a Path to Accelerate Access to Ebola Vaccines: The WHO’s Research and Development Efforts during the 2014–2016 Ebola Epidemic in West Africa.” Current Opinion in Virology, 17: 138–144. https://doi.org/10.1016/j.coviro.2016.03.008. DOI: https://doi.org/10.1016/j.coviro.2016.03.008

Herman, Edward S. and Noam Chomsky. 2011. Manufacturing Consent: The Political Economy of the Mass Media. Knopf Doubleday Publishing Group.

Kingori, Patricia. 2015. “The ‘Empty Choice’: A Sociological Examination of Choosing Medical Research Participation in Resource-Limited Sub-Saharan Africa.” Current Sociology 63 (5): 76378. https://doi.org/10.1177/0011392115590093 DOI: https://doi.org/10.1177/0011392115590093

Kummervold, Per Egil, William S. Schulz, Elizabeth Smout, Luis Fernandez-Luque, and Heidi J. Larson. 2017. “Controversial Ebola Vaccine Trials in Ghana: A Thematic Analysis of Critiques and Rebuttals in Digital News.” BMC Public Health 17 (1): 642. https://doi.org/10.1186/s12889-017-4618-8. DOI: https://doi.org/10.1186/s12889-017-4618-8

Lauer, Helen and Joan Shenton. “Counterproductive Contributions to African Epidemiology.” 2017. Madridge Journal of Immunology 1 (1): 28–39. https://doi.org/10.18689/mjim-1000108. DOI: https://doi.org/10.18689/mjim-1000108

Lévi -Strauss, Claude. 1962. La pensée sauvage. Paris: Editions Plon.

Lock, Margaret, and Vinh-Kim Nguyen. 2011. An Anthropology of Biomedicine. 2nd edition. Oxford: Wiley Blackwell

Lorimer, Jamie. 2007. “Nonhuman Charisma.” Environment and Planning D: Society and Space 25 (5): 911–932. https://doi.org/10.1068/d71j. DOI: https://doi.org/10.1068/d71j

Maurice, John. 2014. “WHO meeting chooses untried Interventions to defeat Ebola.” The Lancet 384 (9948): e45-e46. DOI: https://doi.org/10.1016/S0140-6736(14)61411-2

Nading, Alex M. 2015. “Chimeric Globalism: Global Health in the Shadow of the Dengue Vaccine.” American Ethnologist 42 (2): 356–370. https://www.jstor.org/stable/43867914 DOI: https://doi.org/10.1111/amet.12135

Nguyen, Vinh-Kim. 2005. “Antiretroviral Globalism, Biopolitics, and Therapeutic Citizenship.” In Global Assemblages. Technology, Politics, and Ethics as Anthropological Problems, edited by Aihwa Ong and Stephen J. Collier, 12444. Malden: Blackwell Publishing.

——. 2010. The Republic of Therapy: Triage and Sovereignty in West Africa’s Time of AIDS. Durham: Duke University Press.

Peterson, Kristin and Morenike Oluwatoyin Folayan. 2018. “Ethics and HIV Prevention Research: An Analysis of the Early Tenofovir PrEP Trial in Nigeria.” Bioethics, https://doi.org/10.1111/bioe.12470. DOI: https://doi.org/10.1111/bioe.12470

Pollock, Anne. 2019. Synthesizing Hope: Matter, Knowledge, and Place in South African Drug Discovery. Chicago: University of Chicago Press. DOI: https://doi.org/10.7208/chicago/9780226629216.001.0001

Ryan, Molly J., Tamara Giles-Vernick, and Janice E. Graham. 2019. “Technologies of Trust in Epidemic Response: Openness, Reflexivity and Accountability during the 2014–2016 Ebola Outbreak in West Africa.” BMJ Global Health 4 (1): e001272. https://doi.org/10.1136/bmjgh-2018-001272. DOI: https://doi.org/10.1136/bmjgh-2018-001272

Thiongane, Oumy and Janice Graham. 2021. “Who’s Positively Healthy Enough for an Ebola Vaccine Trial in West Africa?” In Beyond the Endgame: Living with HIV in Post Crisis Times, edited by David Murray, 105-121. Washington: Lexington Books.